Viewing Study NCT00526292


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-01-20 @ 6:20 AM
Study NCT ID: NCT00526292
Status: COMPLETED
Last Update Posted: 2016-02-12
First Post: 2007-09-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-08
Start Date Type: None
Primary Completion Date: 2015-07
Primary Completion Date Type: ACTUAL
Completion Date: 2015-07
Completion Date Type: ACTUAL
First Submit Date: 2007-09-05
First Submit QC Date: None
Study First Post Date: 2007-09-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-01-14
Results First Submit QC Date: None
Results First Post Date: 2016-02-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-01-14
Last Update Post Date: 2016-02-12
Last Update Post Date Type: ESTIMATED